Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
20 25 Search
2024
Prognostic factors and predictive models for patients with lung large cell neuroendocrine carcinoma: Based on SEER database
The Clinical Respiratory Journal
2023
The Surgical Management of Lung Neuroendocrine Neoplasms
Cancers
2023
Clinical significance of MYC family protein expression in surgically resected high‐grade neuroendocrine carcinoma of the lung
Thoracic Cancer
2023
The Unmet Diagnostic and Treatment Needs in Large Cell Neuroendocrine Carcinoma of the Lung
Current Oncology
2022
Prognostic significance of laterality in lung neuroendocrine tumors
Endocrine
2022
Survival After Lobectomy vs. Sublobar Resection for Stage IA Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study
Frontiers in Surgery
2022
Adjuvant chemotherapy, extent of resection, and immunoistochemical neuroendocrine markers as prognostic factors of early‐stage large‐cell neuroendocrine carcinoma
Thoracic Cancer
2022
Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges
Journal of Clinical Medicine
2022
Surgical Principles in the Management of Lung Neuroendocrine Tumors: Open Questions and Controversial Technical Issues
Current Treatment Options in Oncology
2022
Risk factors, survival analysis, and nomograms for distant metastasis in patients with primary pulmonary large cell neuroendocrine carcinoma: A population-based study
Frontiers in Endocrinology
2021
A Clinical Nomogram for Predicting Cancer-Specific Survival in Pulmonary Large-Cell Neuroendocrine Carcinoma Patients: A Population-Based Study
International Journal of General Medicine
2021
An algorithmic approach utilizing CK7, TTF1, beta-catenin, CDX2, and SSTR2A can help differentiate between gastrointestinal and pulmonary neuroendocrine carcinomas
Virchows Archiv
2021
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities
Frontiers in Oncology
2021
Management of Large Cell Neuroendocrine Carcinoma
Frontiers in Oncology
2021
Comprehensive Dissection of Treatment Patterns and Outcome for Patients With Metastatic Large-Cell Neuroendocrine Lung Carcinoma
Frontiers in Oncology
2021
A Population-Based Systematic Clinical Analysis With a Single-Center Case Series of Patients With Pulmonary Large Cell Neuroendocrine Carcinoma
Frontiers in Endocrinology
2021
Survival outcomes of surgery in patients with pulmonary large-cell neuroendocrine carcinoma: a retrospective single-institution analysis and literature review
Orphanet Journal of Rare Diseases
2020
<p>Immune Checkpoint Inhibitor Therapy Achieved Complete Response for Drug-Sensitive<em> EGFR/ALK</em> Mutation-Negative Metastatic Pulmonary Large-Cell Neuroendocrine Carcinoma with High Tumor Mutation Burden: A Case Report</p>
OncoTargets and Therapy
2020
Ubiquitin C‐terminal hydrolase‐L1 has prognostic relevance and is a therapeutic target for high‐grade neuroendocrine lung cancers
Cancer Science
2019
Prognostic factors and survival outcomes according to tumor subtype in patients with breast cancer lung metastases
PeerJ
Additional cited-by details will be shown when available from Crossref